Assessing the person
Establish why the person is fasting, as this affects medicine management and risk. Fasting may occur because of:
- religious observance such as Ramadan
- personal or health-related fasting, including intermittent fasting
- clinical fasting, including pre-procedure fasting or nil-by-mouth (NBM) instructions
Clarify fasting restrictions
Ask people what their fast allows and prohibits. The timing and duration of the fast may vary.
Some religious fasting may have exemptions such as poor health, frailty, travelling, being pre-puberty, and women who are menstruating, pregnant or breastfeeding. People should check with their religious leader for guidance on exemptions.
During the fasting period people may avoid:
- eating and drinking intentionally
- oral and nasal medicines
- smoking
- water used to take medicines
- food or medicines administered by other routes
Shared decision making
Ask people about their plans before the fast begins. Discussing plans early allows you time to review medicines, assess risks and make any necessary treatment changes.
Explain potential medicine-related risks and agree what outcomes are most important to them. Use shared decision making to develop a plan that balances their health needs with their wish to fast whilst minimising harm.
Identifying people at risk
The British Islamic Medical Association (BIMA) Ramadan Compendium is a comprehensive collection of evidence relating to fasting. It covers various medical conditions such as cardiovascular disease, respiratory disease, diabetes, pregnancy and mental health.
The compendium helps healthcare professionals identify the risks to people from fasting based on age, clinical stability, frailty, previous fasting experience and co-morbidities.
Use the compendium to identify people who are at greater risk of harm from fasting and if they should be advised to avoid fasting altogether.
Reviewing medicines
Some medicines may pose greater risks for people who are fasting.
Fasting can lead to changes such as accidental missed doses of medicines, increased dehydration, decreased blood glucose levels, and altered dosing frequency for time critical medicines.
Time critical medicines
Missed or delayed doses of time critical medicines may lead to treatment failure, deterioration and in severe cases can be fatal. Some medicines require consistent administration intervals to maintain therapeutic effect or avoid toxicity. It is important these doses are not missed or delayed and the risk of harm is considered if any changes are made. Examples include:
- antiseizure medicines
- Parkinson’s disease medicines
- anticoagulants
- immunosuppressants
- antipsychotics
Understanding time critical medicines to support improvement (SPS page) aims to increase awareness and understanding of medicines that are more likely to cause harm if they are not taken at their intended timepoint.
Dehydration
Dehydration can increase the risk of Acute Kidney Injury (AKI), hypotension, falls and electrolyte disturbances with some medicines. For example:
- angiotensin converting enzyme inhibitors (ACEIs)
- angiotensin receptor blockers (ARBs)
- ciclosporin
- diuretics
- lithium
- sodium-glucose co-transporter-2 (SGLT-2) inhibitors
- tacrolimus
This risk increases with hot weather and long fasting hours. People should be counselled to increase their water intake during non-fasting hours. They should be advised to break their fast if they have symptoms such as light-headedness, dizziness, strong smelling urine or heart palpitations.
Hypoglycaemia
People living with diabetes who fast are at a higher risk of low blood sugar as they may already be on insulin or taking sulfonylureas. Symptoms of low blood sugar include feeling dizzy, sweating, heart palpitations, confusion and seizures.
People should be counselled to break their fast if they have symptoms of low blood sugar or their blood sugar falls below 4mmol/L.
Administration with food
Some medicines have specific requirements relating to food, such as:
- cefuroxime
- gliclazide
- metformin
- metronidazole
- paroxetine
- prednisolone
- valproate
This list is not exhaustive. Check the electronic Medicines Compendium (eMC) Summary of Product Characteristics, section 4.2 or MHRA Products for administration information.
You may need to move the dosing time to non-fasting hours to maintain administration with food. Or consider if an alternative route or medicine is more appropriate for the fasting period.
Optimising medicines
You may need to consider the following in people who decide to fast and are at low or moderate risk of harm from fasting, based on the BIMA risk stratification tables. Avoid changing a stable medicines regimen where possible.
Any changes to medicines should be discussed, agreed and made in advance of fasting and not when fasting begins.
Communicating the medicines plan
Agree a personalised medicines plan with the individual and their carers. Document any medicine changes, monitoring requirements, circumstances that should prompt review, and when original treatment arrangements should be resumed. Share the plan with relevant healthcare professionals where appropriate.
Where medicines have been temporarily withheld or treatment regimens modified, agree when and how the person should return to their usual regimen.